Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Ethnopharmacol ; 313: 116559, 2023 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-37116730

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Exocarpium Citri grandis (ECG, Huajuhong in Chinese), the epicarp of C. grandis 'Tomentosa', has been used for hundreds of years as an anti-inflammatory, expectorant, hypoglycemic, and lipid-lowering medication in China. Nevertheless, there have been few papers that have explored the mechanism behind ECG's hypolipidemic characteristics from the perspective of treating nonalcoholic fatty liver disease (NAFLD). AIM OF STUDY: The purpose of our study was to confirm the therapeutic and preventative effects of ECG in NAFLD by regulating lipid accumulation and iron metabolism, and to explore the specific mechanism of ECG in enhancing hepatic iron transport and excretion capabilities. STUDY DESIGN: We constructed a NAFLD model by feeding male C57BL/6 J mice with a high-fat diet for 12 weeks. Mice were gavaged with ECG beginning in the seventh week of modeling, and three dosage gradients were established: low dose group (2.5 g/kg/d), medium dose group (5 g/kg/d) y, and high dose group (10 g/kg/d) until the end of model construction in week 12. MATERIALS AND METHODS: We used network pharmacology to analyze the relationship between ECG and NAFLD. In addition, we constructed a nonalcoholic fatty liver disease model by feeding male C57BL/6 J mice a high-fat diet for 12 weeks. Finally, lipid accumulation, iron accumulation, inflammation and oxidative stress were evaluated by serological index detection, histological detection, immunofluorescent and immunohistochemical staining, and western blotting. RESULTS: Network pharmacology confirmed the treatment effect of ECG in NAFLD. Three active components of ECG, including Naringenin, Naringin and Neohesperidin, were detected by UHPLC-HRMS analysis. The results of serum TC, TG, LDL concentration, HE staining, Oil red staining and Nile red staining demonstrated that ECG could improve lipid metabolism disorders. The results of serum iron concentration, liver tissue iron concentration, iron metabolism-related proteins Ferritin light chain, Ferroportin1, Transferrin receptor, and Transferrin demonstrated that ECG improved the iron transport and storage capacities of hepatic cells. CONCLUSIONS: Our results demonstrated that ECG relieved liver injury by inhibiting lipid accumulation and iron accumulation in NAFLD.


Asunto(s)
Trastornos del Metabolismo del Hierro , Enfermedad del Hígado Graso no Alcohólico , Ratones , Masculino , Animales , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Ratones Endogámicos C57BL , Hígado , Trastornos del Metabolismo del Hierro/metabolismo , Trastornos del Metabolismo del Hierro/patología , Hierro/metabolismo , Lípidos/farmacología , Metabolismo de los Lípidos , Dieta Alta en Grasa/efectos adversos
2.
Mol Neurodegener ; 9: 27, 2014 Jul 10.
Artículo en Inglés | MEDLINE | ID: mdl-25011704

RESUMEN

BACKGROUND: The substantia nigra (SN) midbrain nucleus is constitutively iron rich. Iron levels elevate further with age, and pathologically in Parkinson's disease (PD). Iron accumulation in PD SN involves dysfunction of ceruloplasmin (CP), which normally promotes iron export. We previously showed that ceruloplasmin knockout (CP KO) mice exhibit Parkinsonian neurodegeneration (~30% nigral loss) by 6 months, which is prevented by iron chelation. Here, we explored whether known iron-stressors of the SN (1) aging and (2) MPTP, would exaggerate the lesion severity of CP KO mice. FINDINGS: We show that while 5 month old CP KO mice exhibited nigral iron elevation and loss of SN neurons, surprisingly, aging CP KO mice to 14 months did not exacerbate iron elevation or SN neuronal loss. Unlike young mice, iron chelation therapy in CP KO mice between 9-14 months did not rescue neuronal loss. MPTP exaggerated iron elevation in young CP KO mice but did not increase cell death when compared to WTs. CONCLUSIONS: We conclude that there may exist a proportion of substantia nigra neurons that depend on CP for protection against iron neurotoxicity and could be protected by iron-based therapeutics. Death of the remaining neurons in Parkinson's disease is likely caused by parallel disease mechanisms, which may call for additional therapeutic options.


Asunto(s)
Hierro/toxicidad , Neuronas/patología , Trastornos Parkinsonianos/patología , Sustancia Negra/patología , Envejecimiento/patología , Animales , Química Encefálica/fisiología , Ceruloplasmina/deficiencia , Ceruloplasmina/genética , Modelos Animales de Enfermedad , Trastornos del Metabolismo del Hierro/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Enfermedades Neurodegenerativas/patología
3.
AJNR Am J Neuroradiol ; 33(9): 1810-3, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22499840

RESUMEN

Neuroferritinopathy is an autosomal dominant extrapyramidal movement disorder, caused by FTL gene mutations. Iron decreases the MR T2* decay time, therefore increasing the R2* (R2* = 1 /T2*), which correlates with brain tissue iron content. 3T structural and quantitative MR imaging assessment of R2* in 10 patients with neuroferritinopathy demonstrated a unique pattern of basal ganglia cavitation involving the substantia nigra in older patients and increasing thalamic R2* signal intensity detectable during 6 months. Increasing R2* signal intensity in the thalamus correlated with progression on a clinical rating scale measuring dystonia severity. Thalamic R2* signal intensity is a clinically useful method of objectively tracking disease progression in this form of neurodegeneration with brain iron accumulation.


Asunto(s)
Interpretación de Imagen Asistida por Computador/métodos , Trastornos del Metabolismo del Hierro/metabolismo , Sobrecarga de Hierro/metabolismo , Hierro/metabolismo , Distrofias Neuroaxonales/metabolismo , Tálamo/metabolismo , Adulto , Femenino , Humanos , Trastornos del Metabolismo del Hierro/complicaciones , Trastornos del Metabolismo del Hierro/patología , Sobrecarga de Hierro/complicaciones , Sobrecarga de Hierro/patología , Imagen por Resonancia Magnética/métodos , Masculino , Persona de Mediana Edad , Distrofias Neuroaxonales/complicaciones , Distrofias Neuroaxonales/patología , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Tálamo/patología
4.
Neurosci Lett ; 452(2): 204-8, 2009 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-19383440

RESUMEN

Traumatic brain injury (TBI) is a major cause of neurological disability across all ages, but the elderly are particularly vulnerable and have a worse prognosis than younger individuals. To advance the understanding of long-term pathogenesis induced by TBI in the elderly, aged mice (21 -- 24 months) were given a controlled cortical impact (CCI) injury to the sensorimotor cortex, and their brains were analyzed by MRI and histopathology at 1 and 2 months after CCI injury, a post-acute period. A T2 hypointensity was observed in the ipsilateral thalamus but not in the contralateral thalamus or in the thalamus of sham operated, control mice. The hypointensity was co-localized with increased histochemical staining of iron, a paramagnetic substance that causes a shortening of the T2 relaxation time. Since iron catalyzes reactions that lead to toxic free radicals, the deposition of iron in the thalamus raises the possibility that it promotes pathogenesis following TBI. Astrocyte gliosis and microgliosis were also observed in the ipsilateral thalamus in the post-acute period. The ipsilateral internal capsule displayed a trend for a T2 hypointensity, however, unlike the thalamus it did not have an increase of iron or GFAP staining, but it did have evidence of microgliosis. In summary, areas of T2 hypointensity were revealed in both the thalamus and internal capsule during the post-acute period following CCI injury, but the underlying pathology appeared to be distinct between these regions.


Asunto(s)
Lesiones Encefálicas/patología , Corteza Cerebral/lesiones , Gliosis/patología , Cápsula Interna/patología , Trastornos del Metabolismo del Hierro/patología , Tálamo/patología , Factores de Edad , Envejecimiento/metabolismo , Envejecimiento/patología , Animales , Lesiones Encefálicas/metabolismo , Lesiones Encefálicas/fisiopatología , Corteza Cerebral/fisiopatología , Modelos Animales de Enfermedad , Radicales Libres/metabolismo , Gliosis/etiología , Gliosis/fisiopatología , Histocitoquímica , Inmunohistoquímica , Cápsula Interna/metabolismo , Cápsula Interna/fisiopatología , Hierro/metabolismo , Trastornos del Metabolismo del Hierro/metabolismo , Trastornos del Metabolismo del Hierro/fisiopatología , Imagen por Resonancia Magnética , Masculino , Ratones , Ratones Endogámicos C57BL , Degeneración Nerviosa/etiología , Degeneración Nerviosa/patología , Degeneración Nerviosa/fisiopatología , Estrés Oxidativo/fisiología , Tálamo/metabolismo , Tálamo/fisiopatología
5.
FEBS Lett ; 583(6): 1011-6, 2009 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-19230836

RESUMEN

Influence of pH on the extent of lipid peroxidation and the anti-oxidant potential of an organoselenium compound is explored. Acidosis increased the rate of lipid peroxidation both in the absence and presence of Fe (II) in rat's brain, kidney and liver homogenate and phospholipids extract from egg yolk. The organoselenium compound significantly protected lipids from peroxidation, both in the absence and presence of Fe (II). Changing the pH of the reaction medium did not alter the anti-oxidant activity of the tested compound. This study provides in vitro evidence for acidosis-induced oxidative stress in brain, kidney, liver homogenate and phospholipids extract and the anti-oxidant action of the tested organoselenium compound.


Asunto(s)
Compuestos Ferrosos/efectos adversos , Trastornos del Metabolismo del Hierro/etiología , Trastornos del Metabolismo del Hierro/prevención & control , Compuestos de Organoselenio/uso terapéutico , Animales , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Citoprotección/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Compuestos Ferrosos/farmacología , Concentración de Iones de Hidrógeno , Iminas/farmacología , Trastornos del Metabolismo del Hierro/metabolismo , Trastornos del Metabolismo del Hierro/patología , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Malondialdehído/metabolismo , Modelos Biológicos , Compuestos de Organoselenio/farmacología , Fosfolípidos/metabolismo , Ratas , Ratas Wistar , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
6.
Clin Neurophysiol ; 119(8): 1739-1746, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18571983

RESUMEN

OBJECTIVE: Iron is an important oligoelement participating in multiple metabolic processes, including the synthesis of catecholamines, and its deficiency (ID) throughout development is particularly insidious on brain maturation and the emergence of cognitive functions during school age. A working memory (WM) study in 8-10-year-old ID children is presented. It is hypothesized that an impairment in WM exists in ID school-age children and a substantial restoration of this mental ability should occur after iron supplementation. METHODS: Event-related potentials (ERPs) were recorded during the completion of a Sternberg-type task in control, ID and ID-iron supplemented children. RESULTS: ID children showed less correct answers and diminished ERP amplitude in frontal, central, parietal and temporal regions compared to control children. After iron supplementation and normalizing bodily iron stores, behavioral and ERP differences disappeared between ID and control children. CONCLUSIONS: Considering that WM is fundamentally related to attention ability, the results presented here confirm and reinforce previous observations: ID severely diminishes attention [Otero GA, Pliego-Rivero FB, Contreras G, Ricardo J, Fernandez T. Iron supplementation brings up a lacking P300 in iron deficient children. Clin Neurophysiol 2004;115:2259-66] and WM while iron supplementation substantially restores the cognitive capabilities tested. SIGNIFICANCE: This is one of very few reports using ERP showing a diminished WM capability in ID school-age children.


Asunto(s)
Trastornos del Metabolismo del Hierro/complicaciones , Trastornos de la Memoria/dietoterapia , Trastornos de la Memoria/etiología , Memoria a Corto Plazo/fisiología , Recuperación de la Función/fisiología , Análisis de Varianza , Atención/efectos de los fármacos , Atención/fisiología , Células Sanguíneas/fisiología , Niño , Electroencefalografía/métodos , Potenciales Evocados/efectos de los fármacos , Potenciales Evocados/fisiología , Femenino , Hematócrito/métodos , Hemoglobinas/metabolismo , Humanos , Hierro/administración & dosificación , Hierro/sangre , Trastornos del Metabolismo del Hierro/dietoterapia , Trastornos del Metabolismo del Hierro/patología , Masculino , Pruebas Neuropsicológicas , Recuperación de la Función/efectos de los fármacos , Estadísticas no Paramétricas , Factores de Tiempo
7.
Stroke ; 39(5): 1541-7, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18323485

RESUMEN

BACKGROUND AND PURPOSE: Iron plays a central role in many metabolic processes. Under certain pathological situations it accumulates, producing negative effects such as increasing damage by oxidative stress. The present study examined long-term iron accumulation in a stroke model with secondary degeneration, using MRI and histological techniques. METHODS: Male Wistar rats (n=22) were subjected to 60 minutes MCA occlusion. MR images (T2- and T2*-weighted) were obtained weekly between weeks 1 and 7 after reperfusion, and at weeks 10, 14, 20, and 24. Histological iron detection and immunohistochemical examination for different markers (NeuN, GFAP, OX-42, HO-1, and APP) were performed at the 3 survival time points (3, 7, and 24 weeks). RESULTS: Infarcts affecting MCA territory were evident on T2-weighted imaging, and all animals showed deficits on behavioral tests. In the thalamus, T2 hyperintensity was detected 3 weeks after stroke, and disappeared around week 7 when T2*-weighted images showed a marked hypointensity in that area. Histology revealed neuronal loss in the thalamus, accompanied by strong microglial reactivity and microglial HO-1 expression. APP deposits were detected in the thalamus from week 3 on and persisted until week 24. Iron storage was detected in microglia at week 3, in the parenchyma at week 7, and around APP deposits at week 24. CONCLUSIONS: T2*-weighted MRI allows the detection of secondary damage in the thalamus after MCAO. Iron accumulation in the thalamus is mediated by HO-1 expression in reactive microglia.


Asunto(s)
Trastornos del Metabolismo del Hierro/patología , Trastornos del Metabolismo del Hierro/fisiopatología , Accidente Cerebrovascular/patología , Accidente Cerebrovascular/fisiopatología , Tálamo/patología , Tálamo/fisiopatología , Animales , Biomarcadores/análisis , Biomarcadores/metabolismo , Mapeo Encefálico , Modelos Animales de Enfermedad , Gliosis/etiología , Gliosis/patología , Gliosis/fisiopatología , Hemo-Oxigenasa 1/metabolismo , Hierro/metabolismo , Trastornos del Metabolismo del Hierro/etiología , Imagen por Resonancia Magnética , Masculino , Microglía/citología , Microglía/metabolismo , Degeneración Nerviosa/etiología , Degeneración Nerviosa/patología , Degeneración Nerviosa/fisiopatología , Ratas , Ratas Wistar , Accidente Cerebrovascular/metabolismo , Enfermedades Talámicas/etiología , Enfermedades Talámicas/patología , Enfermedades Talámicas/fisiopatología , Tálamo/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA